Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin in Recurrent High-Grade Meningioma
NCT02234050Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 2015
- Primary completion
- Jul 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of trabectedin in meningioma, sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 2015; status: completed.
02
Drugs
trabectedin
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT02234050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234050.